ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

Axicabtagene Ciloleucel in Combination with the 4-1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results from ZUMA-11.

Michael D Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.